These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4301383)

  • 21. [Drug dependance of Mycobacterium tuberculosis].
    Mel'nikov EL
    Probl Tuberk; 1969; 47(5):60-4. PubMed ID: 4983819
    [No Abstract]   [Full Text] [Related]  

  • 22. [Incidence of wild strains of Mycobacterium tuberculosis in variants resistant to minor antibiotics (p-aminosalicylic acid, ethionamide, cycloserine, viomycin, kanamycin)].
    GROSSET J; CANETTI G
    Ann Inst Pasteur (Paris); 1962 Aug; 103():163-84. PubMed ID: 13902273
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bacterial resistance and its relation to chemotherapy].
    Canetti G
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):231-8. PubMed ID: 4973008
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro chemotherapeutic combinations against isoniazid-resistant Mycobacterium tuberculosis and Mycobacterium fortuitum.
    Goldstein E; Eagle MC; LaCasse ML
    Appl Microbiol; 1971 Sep; 22(3):329-33. PubMed ID: 4330314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ultrastructural change in Mycobacterium tuberculosis under the influence of antibacterial preparations (a review of the literature)].
    Kozulitsyna TI; Kozlova NV
    Probl Tuberk; 1979 Oct; (10):49-57. PubMed ID: 116217
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

  • 27. Investigation into the relationship of M ulcerans to M. buruli and other mycobacteria.
    Schröder KH
    Am Rev Respir Dis; 1975 Apr; 111(4):559-62. PubMed ID: 47730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation between the catalase activity and resistance to drugs in Mycobacterium tuberculosis circulating in Southeast Africa].
    Zykov MP
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Mar; 43(3):49-53. PubMed ID: 4295172
    [No Abstract]   [Full Text] [Related]  

  • 29. Antituberculous drug susceptibility testing of Mycobacterium bovis BCG strain Montréal.
    Rousseau P; Dupuis M
    Can J Microbiol; 1990 Oct; 36(10):735-7. PubMed ID: 2253115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program].
    Popov SA; Dorozhkova IR; Medvedeva IM
    Probl Tuberk; 2001; (2):18-20. PubMed ID: 11490457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antimycobacterial activity of capreomycin.
    Lucchesi M
    Antibiot Chemother; 1970; 16():27-31. PubMed ID: 4108891
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H; Mizuno S; Tsukamura S
    Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
    Makarevich NM; Mkrtchian SV; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of pulmonary tuberculosis in patients resistant to major drugs with second line drugs].
    Ibarra JP; Piñeyro J; Trenchi A; Tarallo NH; Lanne de Farriols ME; Cuñarro de Gimeno G; Fernández Latorre I
    Hoja Tisiol; 1967; 24(1):5-88. PubMed ID: 4308762
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of streptomycin, D-cycloserine, kanamycin and florimycin on the prothrombin time in albino mice and rabbits].
    Storozhev IA; Krepak OM
    Antibiotiki; 1967 Feb; 12(2):140-4. PubMed ID: 4298634
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
    Endo K
    Jpn J Antibiot; 1971 Jun; 24(3):149-51. PubMed ID: 4327336
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro drug susceptibility of Mycobacterium bovis BCG Connaught and Tokyo strains.
    Shimizu T; Yasumoto K; Tatano Y; Tomioka H; Sato K; Sano C; Kumon H; Monden K
    J Infect; 2010 Mar; 60(3):248-51. PubMed ID: 20074586
    [No Abstract]   [Full Text] [Related]  

  • 38. Editor's choice: Editorial commentary: Low level INH-resistant BCG: a sheep in wolf's clothing?
    Arend SM; van Soolingen D
    Clin Infect Dis; 2011 Jan; 52(1):89-93. PubMed ID: 21148525
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug resistance in M. tuberculosis cultures determined by the Steenken MIC and Canetti proportion tests.
    Montalbine V; Collins FM; Doster B
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):78-80. PubMed ID: 4985844
    [No Abstract]   [Full Text] [Related]  

  • 40. Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
    Ritz N; Tebruegge M; Connell TG; Sievers A; Robins-Browne R; Curtis N
    Antimicrob Agents Chemother; 2009 Jan; 53(1):316-8. PubMed ID: 18955515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.